Online Only Articles

Single-agent dabrafenib for BRAFV600E-mutated histiocytosis

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
University of Florida Health Cancer Center at Orlando Health, FL, USA
Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Vol. 103 No. 4 (2018): April, 2018 https://doi.org/10.3324/haematol.2017.185298